CTRI/2024/07/069831尚未招募Unknown
An open-label, randomized, pragmatic clinical trial comparing the current clinical practices to pharmacologist guided optimization of antimicrobial therapy based on average creatinine-urea clearance in critically ill patients - A Pilot study - NI
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age 18-75 both sexes
- •Patients admitted to the critical care unit (CCU)
- •Expected to stay more than 24 hours in CCU
- •Receiving at least one antimicrobial agent having renal clearance
- •Patient randomized to the intervention arm giving consent to collect 8-hour urine for average creatinine-urea clearance estimation
排除标准
- •Chronic Kidney disease (CKD)
- •Patient not on renal replacement therapy at the time of enrollment
- •Clinical suspicion for Rhabdomyolysis
- •Pregnancy or breastfeeding.
- •Patients enrolled in other interventional clinical trials simultaneously
研究者
相似试验
进行中（未招募）
1 期
Open-label clinical trial with an open-label extension to investigate the safety of BMN 111 in infants and young children with achondroplasiaMedDRA version: 20.0Level: LLTClassification code 10000452Term: AchondroplasiaSystem Organ Class: 100000004850achondroplasiaEUCTR2020-001055-40-GBBioMarin Pharmaceutical Inc.20
尚未招募
2 期
se of two different medicated Ghee named as Shankhapushpi Ghrita and Kushmanda Ghrita in treatment of Anxiety Disorder.CTRI/2023/04/051478Dr. Maruf Yusuf Hiroli
进行中（未招募）
1 期
Clinical Study to assess positive value of blood plasma from donors having built immunity against the new corona virus (SARS-CoV-2) transfused to patients suffering from SARS-CoV-2 infectioEUCTR2020-001310-38-DEDRK-Bluspendedienst Baden-Württemberg - Hessen gGmbH120
已完成
不适用
Prospective, randomized, open-label, clinical trial evaluating the effects of dipeptidyl peptidase-4 (DPP4) inhibitors on progression of atherosclerotic plaques and endothelial function in type 2 diabetic patientstype 2 diabetesJPRN-UMIN000011752ational Defense Medical College66
已完成
4 期
Prospective, randomized, open-label, clinical trial evaluating the effects of pioglitazone on progression of atherosclerotic plaques, endothelial function, and markers for anti-inflammatory properties/obesity/antioxidative propertiesdiabetesJPRN-UMIN000002963ational Defense Medical College60